Case Report

Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma

Table 2

The literature review of cryoglobulin and renal diseases in malignant mesothelioma.

First AuthorYearDisease siteComplementCryoglobulinChemotherapy for mesotheliomaRenal Pathology

Schroeter1986PleuraNormalNACyclophosphamide, doxorubicin, hydrochloride, and decarbonizeMCNS
Venzano1990PleuraNANANAMCNS
Absy1992PleuraNANACarboplatinFSGS
Tanaka1994PleuraNormalNACarboplatin, etoposideMesPGN
Galesic2000PleuraNormalNANone (corticosteroid)MN
Sakamoto2000PleuraNANANone (surgery)MN
Farmer2001Pleura and brain metastasisNANANone (corticosteroid)MCNS
Bacchetta2009TestisNormalNACisplatin and pemetrexedMCNS
Li2010PleuraNormalNAGemcitabine and carboplatinMCNS
Dogan2012PleuraNANANone (surgery)Not examined
Suzuki2014PleuraNormalNANone (conservative)MCNS
Tsukamoto2015Pleura, pulmonary, and skull metastasisNANACarboplatin, pemetrexed, and gemcitabineMCNS
Pu2016PleuraNANACisplatin and pemetrexedMN
Bickel2016PleuraNANACarboplatin, pemetrexed, vinorelbine, and pembrolizumabMCNS
Yildiz2016PleuraNormalNANone (corticosteroid)MCNS
NagaiPresent casePleural mesothelioma and bone metastasisLow C4PositiveCisplatin, pemetrexed, carboplatin, nivolumab, gemcitabine, and vinorelbineNot examined

MCNS: minimal-change nephrotic syndrome; FSGS: focal segmental glomerulosclerosis; MesPGN: mesangial proliferative glomerulonephritis: MN: membranous nephropathy.